Ondansetron 4 mg orodispersible/rapid oral solution tablets
€26,904
Award value
21% under estimate
Bexal farmaceutica SA
3 contracts won, worth €39,168, from 3 public buyers.
Main sectors Medical equipment & pharmaceuticals 2
Follow this company
We email you when this company wins a new contract. Free, one click to stop.
Relations
Who this company works for
- Gerencia de Atención Primaria del Área de Salud de Gran Canaria 1 contract €26,904
- Gerencia de Atención Primaria del Area de Salud de Tenerife 1 contract €11,954
- ICS - Gerència de compres 1 contract €310
Shares of the 3 contracts this company has won.
Radar
Contracts expiring soon
Contracts this company holds that end within the next two years. The specification for the replacement is usually shaped 18 to 26 months before the notice appears.
-
Ondansetron 4 mg orodispersible/rapid oral solution tablets
€26,904 current contract
12 months
Oct 2027
Register
Contracts won
Each bar compares an award with the largest on this page, €26,904.
Supply of Ondansetron 4 mg orodispersible tablets for health centres under the Tenerife Primary Care Management
€11,954
Award value
Adquisicio medicacio
€310
Award value
3.8% under estimate